Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory effects of glycopyrronium added to indacaterol/mometasone on allergen-induced late asthmatic response
2019-001762-14Phase 3Active
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of indacaterol acetate + glycopyrronium bromide + mometasone furoate and atectura breezhaler in asthma (2 arms), sponsored by University Medical Center Groningen. Started Jul 2020; status: active.
02
Drugs
indacaterol acetate + glycopyrronium bromide + mometasone furoateatectura breezhaler
03
Conditions
asthma
Beyond the preview
Go deeper on 2019-001762-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001762-14.